首页 | 本学科首页   官方微博 | 高级检索  
     

诱导化疗联合三维适形放射治疗对局部晚期非小细胞肺癌治疗的临床研究
引用本文:吴荣,郑伟. 诱导化疗联合三维适形放射治疗对局部晚期非小细胞肺癌治疗的临床研究[J]. 中华肿瘤防治杂志, 2006, 13(7): 526-527
作者姓名:吴荣  郑伟
作者单位:中国医科大学附属第二医院肿瘤科,辽宁,沈阳,110004;中国医科大学附属第二医院肿瘤科,辽宁,沈阳,110004
摘    要:目的:评价诱导化疗加三维适形放射治疗(3DCRT)治疗局部晚期非小细胞肺癌(non-small cell lung cancer,NSCLC)的疗效及并发症。方法:经病理细胞学确诊的35例局部晚期NSCLC患者,采用在3DCRT治疗前给予2~4个周期多西他赛75mg/(m2·d),21d为1个周期的化疗。结果:中位总生存期18个月,1年生存率为71·4%,2年生存率为37·1%。毒副反应患者能耐受。结论:诱导化疗加三维适形放疗治疗晚期NSCLC可延长生存期,但并不增加放射不良反应。

关 键 词:  非小细胞肺/药物疗法  非小细胞肺/放射疗法  放射疗法  适形
文章编号:1673-5269(2006)07-0526-02
收稿时间:2005-07-09
修稿时间:2005-10-20

Induction chemotherapy combined with three-dimensional conformal radiation therapy for locally advanced non small cell lung cancer
WU Rong,ZHENG Wei. Induction chemotherapy combined with three-dimensional conformal radiation therapy for locally advanced non small cell lung cancer[J]. Chinese Journal of Cancer Prevention and Treatment, 2006, 13(7): 526-527
Authors:WU Rong  ZHENG Wei
Abstract:OBJECTIVE:To evaluate the effect and complication of induction chemotherapy combined with three-dimensional conformal radiation therapy (3DCRT) for local advanced non small cell lung cancer (NSCLC). METHODS: Thirty-five patients with locally advanced NSCLC were allotted to study. Before 3DCRT, the induction chemotherapy was administered with 2-4 cycles of taxotere 75 mg/m~2 on D1 in the 21 day cycle. RESULTS: The overall median survival time was 18 months. The 1-year overall survival rate and the 2-year overall survival rate were 71.4% and 37.1%, respectively. The treatment was well tolerated. CONCLUSION: The addition of induction chemotherapy to 3DCRT takes a survival advanced for local NSCLC without increasing toxicities.
Keywords:carcinoma   non small cell lung/drug therapy  carcinoma non small cell lung/radiotherapy  radiotherapy   conformal
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号